Nath Bio-Genes (India) Limited (NATHBIOGEN) — Cash Flow Reinvestment Rate
Nath Bio-Genes (India) Limited (NATHBIOGEN) has a Cash Flow Reinvestment Rate of 0.45x as of March 2025, reinvesting Rs79.20 Million (capex Rs79.20 Million ) from operating cash flow of Rs175.81 Million. Explore NATHBIOGEN capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Nath Bio-Genes (India) Limited Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Nath Bio-Genes (India) Limited across 10 annual periods. Also explore Nath Bio-Genes (India) Limited (NATHBIOGEN) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Nath Bio-Genes (India) Limited (2013–2025)
Year-by-year capital reinvestment analysis for Nath Bio-Genes (India) Limited. For live market cap and broader valuation context, see Nath Bio-Genes (India) Limited (NATHBIOGEN) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | Rs118.82 Million | Rs175.81 Million | Rs79.20 Million | ▲ +16.1% |
| 2024 | 0.58x | Rs357.97 Million | Rs614.80 Million | Rs83.93 Million | ▲ +311.2% |
| 2023 | 0.14x | Rs54.33 Million | Rs383.67 Million | Rs25.49 Million | ▼ -88.5% |
| 2022 | 1.23x | Rs210.32 Million | Rs170.46 Million | Rs210.17 Million | ▼ -88.2% |
| 2021 | 10.47x | Rs116.49 Million | Rs11.13 Million | Rs115.98 Million | ▲ +512.0% |
| 2020 | 1.71x | Rs162.04 Million | Rs94.74 Million | Rs162.03 Million | ▲ +38.6% |
| 2017 | 1.23x | Rs41.26 Million | Rs33.43 Million | Rs41.26 Million | ▲ +1080.3% |
| 2015 | 0.10x | Rs7.06 Million | Rs67.55 Million | Rs7.06 Million | ▼ -45.7% |
| 2014 | 0.19x | Rs28.95 Million | Rs150.28 Million | Rs28.95 Million | ▼ -87.2% |
| 2013 | 1.50x | Rs213.54 Million | Rs142.11 Million | Rs213.54 Million | — |